$A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML$

A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML

Bibliographic Details
Main Authors:	Brian A. Jonas, Laura A. Potter, Maria Galkin, Joseph M. Tuscano
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Leukemia Research Reports
Subjects:	Decitabine Bortezomib Pegylated liposomal doxorubicin Acute myeloid leukemia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048923000146

Internet